In a recent InvestorIntel interview, Tracy Weslosky spoke with Greg Fenton, CEO and Director of ZEN Graphene Solutions Ltd. (TSXV: ZEN) about Health Canada’a approval this week of the ZENGuard™ disposable face mask with the company’s biocidal coating.
In this InvestorIntel interview, which may also be viewed on YouTube (click here to subscribe to the InvestorIntel Channel), Greg said that the graphene based ZENGuard™ coating on a mask kills airborne pathogens like bacteria, fungi and viruses. Explaining why it is the ‘gold standard’ for face masks, Greg discusses how as a result of the review, Health Canada has validated that ZENGuard™-enhanced surgical masks are safe for use by Canadians.
Responding to the questions on the technology associated with the ZENGuard™ masks, Greg provides insight into the impact of this approval and what this means for ZEN Graphene. This includes the application of their biocidal coating in other spaces such as the HVAC market.
To watch the full interview, click here.
About ZEN Graphene Solutions Ltd.
ZEN is a nanotechnology company developing and commercializing next-gen healthcare solutions in the areas of disease prevention, detection and treatment. ZEN is currently focused on commercializing ZENGuardTM, a patent-pending coating with 99% effective antimicrobial activity against COVID-19, and the potential to use similar compounds as pharmaceutical products against many other infectious diseases. The company also has an exclusive agreement to be the global commercializing partner for a newly developed, highly scalable, aptamer-based rapid pathogen detection technology.
To learn more about ZEN Graphene Solutions Ltd., click here
Disclaimer: ZEN Graphene Solutions Ltd. is an advertorial member of InvestorIntel Corp.
This interview, which was produced by InvestorIntel Corp. (IIC) does not contain, nor does it purport to contain, a summary of all the material information concerning the “Company” being interviewed. IIC offers no representations or warranties that any of the information contained in this interview is accurate or complete.
This presentation may contain“forward-looking statements” within the meaning of applicable Canadian securities legislation. Forward-looking statements are based on the opinions and assumptions of management of the Company as of the date made. They are inherently susceptible to uncertainty and other factors that could cause actual events/results to differ materially from these forward-looking statements. Additional risks and uncertainties, including those that the Company does not know about now or that it currently deems immaterial, may also adversely affect the Company’s business or any investment therein.
Any projections given are principally intended for use as objectives and are not intended, and should not be taken, as assurances that the projected results will be obtained by the Company. The assumptions used may not prove to be accurate and a potential decline in the Company’s financial condition or results of operations may negatively impact the value of its securities. Prospective investors are urged to review the Company’s profile on Sedar.com and to carry out independent investigations in order to determine their interest in investing in the Company.
If you have any questions surrounding the content of this interview, please email [email protected].